About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker EDSA

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Nov 12, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Phillip Gross1.10M7.8%SCHEDULE 13G ↗
Nov 12, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Robert Atchinson1.10M7.8%SCHEDULE 13G ↗
Nov 12, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Adage Capital Management, L.P.1.10M7.8%SCHEDULE 13G ↗
Nov 4, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Israel A. Englander1.18M8.7%SCHEDULE 13G/A ↗
Nov 4, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Millennium Group Management LLC1.18M8.7%SCHEDULE 13G/A ↗
Nov 4, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Millennium Management LLC1.18M8.7%SCHEDULE 13G/A ↗
Nov 4, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Integrated Core Strategies (US) LLC1.17M8.7%SCHEDULE 13G/A ↗
Aug 26, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Jon M. Plexico953,7396.9%SCHEDULE 13G ↗
Aug 26, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Stonepine GP, LLC953,7396.9%SCHEDULE 13G ↗
Aug 26, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Stonepine Capital, L.P.953,7396.9%SCHEDULE 13G ↗
Aug 26, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Stonepine Capital Management, LLC953,7396.9%SCHEDULE 13G ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Pardeep Nijhawan2.61M16.3%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
The New Nijhawan Family Trust 201532,6090.2%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
1968160 Ontario Inc.53,1040.4%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
The Digestive Health Clinic Inc.32,0130.2%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Pardeep Nijhawan Medicine Professional Corporation1.16M7.8%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Venkataraman Balaji1.36M10.0%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Morgan Adam1.36M10.0%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Capital Management LLC1.36M10.0%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Capital Investment Management LP1.36M10.0%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Capital Holdings LLC1.33M9.8%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Horizon GP LLC25,0700.2%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Capital Opportunity Fund II LLC250,0001.9%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Horizon Fund LP25,0700.2%SCHEDULE 13D/A ↗
Aug 25, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Velan Capital Master Fund LP1.08M8.0%SCHEDULE 13D/A ↗
Jun 18, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Israel A. Englander520,6855.4%SCHEDULE 13G ↗
Jun 18, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Millennium Group Management LLC520,6855.4%SCHEDULE 13G ↗
Jun 18, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Millennium Management LLC520,6855.4%SCHEDULE 13G ↗
Jun 18, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Integrated Core Strategies (US) LLC520,6855.4%SCHEDULE 13G ↗
Jun 16, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Pardeep Nijhawan2.21M20.0%SCHEDULE 13D/A ↗
Jun 16, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
The New Nijhawan Family Trust 201532,6090.3%SCHEDULE 13D/A ↗
Jun 16, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
1968160 Ontario Inc.53,1040.6%SCHEDULE 13D/A ↗
Jun 16, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
The Digestive Health Clinic Inc.32,0130.3%SCHEDULE 13D/A ↗
Jun 16, 2026SCHEDULE 13D/A (amended)EDSA
Edesa Biotech, Inc.
Pardeep Nijhawan Medicine Professional Corporation1.16M11.2%SCHEDULE 13D/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Daniel Mack00.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Wilmot B. Harkey00.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Nantahala Capital Management, LLC00.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
David Rosen687,5007.7%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Rubric Capital Management LP687,5007.7%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Jon M. Plexico30,0000.3%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Stonepine GP, LLC30,0000.3%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Stonepine Capital, L.P.30,0000.3%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Stonepine Capital Management, LLC30,0000.3%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Steven A. Cohen20.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Point72 Capital Advisors, Inc.20.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)EDSA
Edesa Biotech, Inc.
Point72 Asset Management, L.P.20.0%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Alex Silverstein600,0007.2%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Sirenia Capital Management LP600,0007.2%SCHEDULE 13G ↗
Mar 16, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Perceptive Life Sciences Master Fund, Ltd.563,2396.7%SCHEDULE 13G ↗
Mar 16, 2026SCHEDULE 13GEDSA
Edesa Biotech, Inc.
Joseph Edelman563,2396.7%SCHEDULE 13G ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 9:43 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances